Author:
Schmitt Brian,Wilt Timothy J,Schellhammer Paul F,DeMasi Vincenzo,Sartor Oliver,Crawford E.David,Bennett Charles L
Reference29 articles.
1. Cancer statistics, 2000;Greenlee;CA Cancer J Clin,2000
2. Aronson N, Seidenfeld J, Samson DJ, et al: Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostatic cancer. Evidence Report/Technology Assessment Number 4. (Prepared by the Blue Cross and Blue Shield Association Evidence-Based Practice Center under Contract No. 290-97-0015.) Agency for Health Care Policy and Research Publication No. 99-E0012. Rockville, Md: Agency for Health Care Policy and Research, May 1999.
3. A controlled trial of castration with and without nilutamide in metastatic prostate carcinoma;Beland;Cancer,1990
4. Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer;Boccardo;Eur J Cancer,1993
5. Complete androgen blockade versus chemical castration in advanced prostatic cancer;Bono;Urol Int,1998
Cited by
109 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献